Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma. (Record no. 9983576)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01510 a2200433 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250513165114.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 199904s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0169-5002 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/s0169-5002(98)00072-5 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Purohit, A |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19990415 |
| 245 00 - TITLE STATEMENT | |
| Title | Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Lung cancer (Amsterdam, Netherlands) |
| Date of publication, distribution, etc. | Nov 1998 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 119-25 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cisplatin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon alpha-2 |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mesothelioma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pleural Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moreau, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dietemann, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Seibert, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pauli, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wihlm, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Quoix, E |
| 773 0# - HOST ITEM ENTRY | |
| Title | Lung cancer (Amsterdam, Netherlands) |
| Related parts | vol. 22 |
| -- | no. 2 |
| -- | p. 119-25 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/s0169-5002(98)00072-5">https://doi.org/10.1016/s0169-5002(98)00072-5</a> |
| Public note | Available from publisher's website |
No items available.